Wearable technology has revolutionized the way we're able to collect objective data in real-world settings, says our Dr. Eileen Hacker.

Learn how wearable technology is helping oncology nurses with cancer research. brnw.ch/21wIM9b Oncology Nursing News #EndCancer

What does the future of gastrointestinal cancer research hold? Dr. Michael Overman shares areas of focus, including endoscopic techniques to alter immunotherapy responses, particularly through microbiome modulation. brnw.ch/21wIM3y Michael overman OncLive.com #EndCancer

Our esteemed leader, Colin Dinney, speaking on intravesical therapy for NMIBC

He has led and continues to contribute to studies in this space great role model for the surgeon scientist.

MD Anderson Cancer Center #oncsurgery

When pain lingers for more than two weeks and won’t go away with medication, that’s a big red flag, says our Dr. Pamela Soliman.

Learn about ovarian cancer pain and when to see your doctor: brnw.ch/21wILUm Pamela T. Soliman MD #EndCancer

Brittney Cotta, MD speaking on radiogenomics im kidney cancer.

Great addition to our MD Anderson Cancer Center faculty

Excited to see her career progress.

MD Anderson Cancer Center Christopher G. Wood
#CGW24

Fabulous presentation by Alexa Glencer on ASBrS member survey on management of #IBC . Important not to extrapolate data from other studies to this unique type of #breastcancer , eg axillary surgery de-escalation. #ASBrS24 MD Anderson Cancer Center Anthony Lucci Wendy Woodward MDPhD IBC Research Fdn

In the RE-RAFFLE study led by our Dr. Blessie Nelson, patients who had multiple tumors with RAF alterations were rechallenged with a second RAF inhibitor.

Learn about the findings of this study, and other new research at MD Anderson here: bit.ly/3VRAcd5 Blessie Elizabeth Nelson MD, DMRT…

Inflammatory breast cancer is a rare, aggressive subtype of #BreastCancer .

Here, our Drs. Rachel Layman, @AnthonyLucci1, Bora Lim, MD and Wendy Woodward MDPhD share how MD Anderson's multi-disciplinary expertise leads to better outcomes for patients with this disease. #BCSM #EndCancer

You can still register for MD Anderson’s Interdisciplinary Pain and Opioid Crisis Virtual Seminar on April 19-20.

Learn more: brnw.ch/21wIL1B #EndCancer

MD Anderson has been named one of Becker's Hospital Review’s 150 top places to work in healthcare for our dedication to workplace excellence and our employees' satisfaction and wellbeing. Learn more: brnw.ch/21wIJFV #EndCancer

Can drinking alcohol harm your microbiome? And how much is safe to drink?

Get insights from our Dr. Carrie Daniel-MacDougall: brnw.ch/21wIJld Carrie Daniel Mac #microbiome #EndCancer

“We never could’ve lived the wonderful life we did if we hadn’t had complete confidence in Dr. Larissa Meyer and her amazing team,” says caregiver Mac Dunwoody. brnw.ch/21wIIUW Larissa Meyer Amir Jazaeri #OvaricanCancer #EndCancer

Deeply grateful to the SU2C MEG VOSBURG T-CELL LYMPHOMA DREAM TEAM for supporting our CAR NK program to target CD5. And thrilled to share FDA clearance for a clinical trial targeting CD5 CAR NK cells in patients with T cell lymphoma. Stand Up To Cancer MD Anderson Cancer Center Center for Cell and Gene Therapy

“We don’t know what a colon polyp actually is until we remove it and send it for biopsy. But if it turns out to be precancerous, we may have just spared you from a future colon cancer diagnosis,” says Dr. Therese Bevers. Learn more: brnw.ch/21wIIzR Farhad Ravandi #EndCancer

Individuals with HER2 positive breast cancer who have already had preoperative systemic therapy are more likely to survive after breast-conserving therapy, says Aiham qdaisat of findings from an observational cohort study. brnw.ch/21wIHDl OncLive.com #BCSM #EndCancer

Facing a cancer diagnosis and treatment is stressful, especially when you already have mental health concerns.

Our Dr. Erica Taylor shares tips for managing your mental health during treatment: brnw.ch/21wIHt3 #EndCancer

The future is bright for NK cell therapy with so many innovative products and scientific discoveries in the pipeline 🤩! Katy Rezvani, M.D., Ph.D MD Anderson Cancer Center #NK #Engineering #CAR

Read about MD Anderson research presented at #AACR24 , including initial clinical data for studies of B-cell non-Hodgkin #lymphoma , #melanoma and #BreastCancer : brnw.ch/21wIH8v BioSpace #EndCancer

Thank you to everyone who stopped by our booth at #AACR24 to discuss the latest cancer research advances. We hope to see you all again next year. #EndCancer

Dr. Krina Patel discusses U.S. FDA’s approval of ide-cel for adult patients with triple class–exposed relapsed/refractory #MultipleMyeloma .

Watch here: brnw.ch/21wIGvQ OncLive.com Krina Patel #EndCancer